|Adult ADHD Home||Succeed at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|The Organized Life||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Parent Support Group|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||High School & College||Accommodations|
|IEPs & 504s||ADHD Study Skills||ADHD School Guide|
|Working with School||School Organization Help||College Survival Guide|
|Social Skills at School||For Teachers Only||Is it LD? A Self Test|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
FDA Questions Use of Antipsychotics in Children
Antipsychotic medications can carry serious risks, especially for children, warn experts.
Friday November 21st - 11:08am
Drug regulators need to do more to warn physicians and patients about the serious risks of antipsychotic medications, especially for children, a panel of FDA experts said on November 18.
Panel members were concerned with the use of Risperdal, as well as others in its class, such as Zyprexa, Seroquel, Abilify, and Geodon. More than 389,000 children and teenagers were treated last year with Risperdal, 240,000 of whom were 12 or younger. In many cases, the drug was prescribed to treat attention deficit disorder (ADD ADHD).
The risks include substantial weight gain, metabolic disorders, muscular tics that can be permanent, and in rare cases, fatal strokes. Because the drug has not been approved for attention deficit disorder (it is currently prescribed off-label), panel members felt the risks were too great to justify its use in treating ADHD.
In the past year, Risperdal prescriptions to patients 17 and younger increased 10 percent, partly due to the increase in the diagnosis of pediatric bipolar disorder.
As of now, no studies have been done to test the drugs’ long-term safety.
What do you think of this article? Share your comments on www.ADDConnect.com, ADDitude's community site. Check out the new ADHD Medication User Reviews and the ADHD Adults Support Group. Your fellow ADDers want to hear from you!